Cardiovascular Risk Linked to Chronic Kidney Disease--But Who Actually Has Chronic Kidney Disease?

Rule, Andrew D.; Textor, Stephen C.
October 2005
Mayo Clinic Proceedings;Oct2005, Vol. 80 Issue 10, p1267
Academic Journal
Looks into the close relationship between kidney failure and cardiovascular disease. Emphasis on the prevalence of cardiovascular risk factors based on estimated kidney function; Utilization of the Modification of Diet in Renal Disease equation to estimate the burden of reduced kidney function in the general population; Belief of the authors that there are major opportunities for the medical community to actively benefit patients with chronic kidney disease who often have multiple cardiovascular risk factors.


Related Articles

  • Çocukluk çağı kronik böbrek hastalığında kardiyovasküler risk faktörleri. Elmacı, Ahmet Midhat // Dicle Medical Journal / Dicle Tip Dergisi;2013, Vol. 40 Issue 1, p169 

    Cardiovascular diseases are the principal cause of morbidity and mortality among child and adults with chronic renal disease. Recent data demonstrate a high incidence and prevalence of traditional and uremia related cardiovascular risk factors in children. This review summarizes the current...

  • The Heart of Your Kidneys.  // Cleveland Clinic Men's Health Advisor;Sep2015, Vol. 17 Issue 9, p1 

    The article discusses the aspects of cardiovascular complications and the risks factors related to chronic kidney disease (CKD). Topics discussed include the aspects of CDK complications considering the primary function of the kidney which is to filter the waste product in the body's blood, the...

  • The HUGE formula (hematocrit, urea and gender): association with cardiovascular risk. ROBLES, N. R.; FELIX, F. J.; FERNANDEZ-BERGES, D.; PEREZ-CASTÁN, J.; ZARO, M. J.; LOZANO, L.; ALVAREZ-PALACIOS, P.; GARCIA-TRIGO, A.; TEJERO, V.; MORCILLO, Y.; HIDALGO, A. B. // European Review for Medical & Pharmacological Sciences;Jul2013, Vol. 17 Issue 14, p1889 

    OBJECTIVES: To evaluate the relationship between chronic renal failure (CFR) defined through HUGE (hematocrit, urea and gender) formula score and the patient's cardiovascular risk measured through cardiovascular disease antecedents such as ischemic cardiopathy, cerebrovascular disease and...

  • Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Ninomiya, Toshiharu; Kiyohara, Yutaka; Kubo, Michiaki; Tanizaki, Yumihiro; Doi, Yasufumi; Okubo, Ken; Wakugawa, Yoshiyuki; Hata, Jun; Oishi, Yoshinori; Shikata, Kentaro; Yonemoto, Koji; Hirakata, Hideki; Iida, Mitsuo // Kidney International;Jul2005, Vol. 68 Issue 1, p228 

    Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Background. Chronic kidney disease has been shown to be an independent risk factor for cardiovascular disease in high-risk populations. However, this relationship is inconclusive in...

  • Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: Correlation with cardiovascular risk. Kruger, A.; Stewart, J.; Sahityani, R.; O'Riordan, E.; Thompson, C.; Adler, S.; Garrick, R.; Vallance, P.; Goligorsky, M S // Kidney International;Jul2006, Vol. 70 Issue 1, p157 

    Prediction of cardiovascular (CV) complications represents the Achilles' heel of end-stage renal disease. Surrogate markers of endothelial dysfunction have been advocated as predictors of CV risk in this cohort of patients. We have recently adapted a noninvasive laser Doppler flowmetry (LDF)...

  • Cardiovascular complications in pediatric end-stage renal disease. Parekh, Rulan S.; Gidding, Samuel S. // Pediatric Nephrology;Feb2005, Vol. 20 Issue 2, p125 

    Mortality from end-stage renal disease (ESRD) is often due to cardiac causes. Although cardiovascular complications of ESRD have long been recognized, only recently has the presence of traditional cardiovascular risk factors been associated with late cardiovascular complications. This review...

  • World Kidney Day 2011: Protect your kidneys, save your heart. Couser, William; Riella, Miguel // Pediatric Nephrology;Mar2011, Vol. 26 Issue 3, p329 

    The author reflects on the celebration of the 6th World Kidney Day (WKD) on March 10, 2011, which is an annual event sponsored by the International Society of Nephrology and the International Federation of Kidney Foundations that seeks to raise public and government awareness about the dangers...

  • Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment. Ru-Dee Ting; Keech, Anthony C.; Drury, Paul L.; Donoghoe, Mark W.; Hedley, John; Jenkins, Alicia J.; Davis, Timothy M. E.; Lehto, Seppo; Celermajer, David; Simes, R. John; Rajamani, Kushwin; Stanton, Kim // Diabetes Care;Feb2012, Vol. 35 Issue 2, p218 

    OBJECTIVE--Diabetic patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] 30-59 mL/min/1.73 m²) are at particular cardiovascular risk. Fenofibrate's safety in these patients is an issue because it may elevate plasma creatinine. Furthermore, guidelines regarding...

  • A look at the upper heart chamber: the left atrium in chronic kidney disease. Paoletti, Ernesto; Zoccali, Carmine // Nephrology Dialysis Transplantation;Oct2014, Vol. 29 Issue 10, p1847 

    Altered left ventricular (LV) mass and function are classical hallmarks of cardiomyopathy in chronic kidney disease (CKD). The left atrium (LA), a heart chamber exquisitely sensitive to volume overload and diastolic function, is an independent predictor of death and adverse cardiovascular (CV)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics